Transdermal anti-anginal pharmaceutical dosage

Details Transdermal anti-anginal pharmaceutical dosage Transdermal anti-anginal pharmaceutical dosage

A - Human Necessities

61

K

167/159, 167/251

A61K 9/70 (2006.01)

Patent

CA 1288698

ABSTRACT NOVEL TRANSDERMAL ANTI ANGINAL PHARMACEUTICAL ABSORPTION DOSAGE UNIT AND PROCESS FOR ITS ADMINISTRATION Novel transdermal nitroglycerin or other anti-anginal pharmaceutical polymer matrix dosage units have been developed which comprise a backing layer, an adjoining layer of a solid polymer matrix in which the pharmaceutical is microdispersed, and a biologically acceptable adhesive poly- mer layer which has dispersed one or more skin permeation enhancers. Novel process of administration of the anti- anginal pharmaceutical using the novel polymer matrix dosage units is also provided.

516892

Affiliated with

Also associated with

Rating

Transdermal anti-anginal pharmaceutical dosage does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal anti-anginal pharmaceutical dosage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal anti-anginal pharmaceutical dosage will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1184527